Free Stock Screener
Load Save Create a watchlist HelpProfit margin
Debt to assets
Cash flow
Balance sheet
(in millions USD) | 30 May 2009 | 27 Feb 2009 | |||
---|---|---|---|---|---|
Current assets | |||||
Cash | $0.000003 | $0.000003 | |||
Short term investments | |||||
Net receivables | |||||
Inventory | |||||
Other current assets | |||||
Total current assets | $0.000003 | $0.000003 | |||
Long term investments | |||||
Property, plant & equipment | |||||
Goodwill | |||||
Intangible assets | |||||
Other assets | |||||
Deferred long term asset charges | |||||
Total assets | $0.000003 | $0.000003 | |||
Current liabilities | |||||
Accounts payable | $0.00209 | $0.00164 | |||
Short long term debt | |||||
Other current liabilities | |||||
Total current liabilities | $0.002507 | $0.002042 | |||
Long term debt | |||||
Other liabilities | |||||
Deferred long term liabilities | |||||
Minority interest | |||||
Total liabilities | $0.002507 | $0.002042 | |||
Stockholders' equity | |||||
Stock option warrants | |||||
Common stock | $0.004792 | $0.004741 | |||
Retained earnings | -$1.060466 | -$1.054941 | |||
Treasury stock | |||||
Capital surplus | $1.05317 | $1.048161 | |||
Other stockholder equity | |||||
Total stockholder equity | -$0.002504 | -$0.002039 | |||
Net tangible assets | -$0.002504 | -$0.002039 |
(in millions USD) | 2009 | 2008 | ||
---|---|---|---|---|
Current assets | ||||
Cash | $0.000003 | $0.000002 | ||
Short term investments | ||||
Net receivables | ||||
Inventory | ||||
Other current assets | ||||
Total current assets | $0.000003 | $0.000002 | ||
Long term investments | ||||
Property, plant & equipment | ||||
Goodwill | ||||
Intangible assets | ||||
Other assets | ||||
Deferred long term asset charges | ||||
Total assets | $0.000003 | $0.000002 | ||
Current liabilities | ||||
Accounts payable | $0.00209 | $0.00179 | ||
Short long term debt | ||||
Other current liabilities | ||||
Total current liabilities | $0.002507 | $0.001919 | ||
Long term debt | ||||
Other liabilities | ||||
Deferred long term liabilities | ||||
Minority interest | ||||
Total liabilities | $0.002507 | $0.001919 | ||
Stockholders' equity | ||||
Stock option warrants | ||||
Common stock | $0.004792 | $0.004589 | ||
Retained earnings | -$1.060466 | -$1.039639 | ||
Treasury stock | ||||
Capital surplus | $1.05317 | $1.033133 | ||
Other stockholder equity | ||||
Total stockholder equity | -$0.002504 | -$0.001917 | ||
Net tangible assets | -$0.002504 | -$0.001917 |
Income statement
(in millions USD) | 30 May 2009 | 27 Feb 2009 | |||
---|---|---|---|---|---|
Revenue | |||||
Total revenue | |||||
Cost of revenue | |||||
Gross profit | |||||
Operating activities | |||||
Research & development | |||||
Selling, general & administrative | $0.005525 | $0.00506 | |||
Non-recurring | |||||
Other operating expenses | |||||
Total operating expenses | $0.005525 | $0.00506 | |||
Operating income | -$0.005525 | -$0.00506 | |||
Income from continuing operations | |||||
Net other income | |||||
EBIT | -$0.005525 | -$0.00506 | |||
Interest expense | |||||
Income before tax | -$0.005525 | -$0.00506 | |||
Income tax expense | |||||
Minority interest | |||||
Net income from continuing ops | -$0.005525 | -$0.00506 | |||
Non-recurring events | |||||
Discontinued operations | |||||
Extraordinary items | |||||
Effect of accounting change | |||||
Other items | |||||
Net income | |||||
Net income | -$0.005525 | -$0.00506 | |||
Income (for common shares) | -$0.005525 | -$0.00506 |
(in millions USD) | 2009 | 2008 | ||
---|---|---|---|---|
Revenue | ||||
Total revenue | $0.000092 | |||
Cost of revenue | ||||
Gross profit | $0.000092 | |||
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | $0.020919 | $0.050208 | ||
Non-recurring | ||||
Other operating expenses | ||||
Total operating expenses | $0.020919 | $0.050208 | ||
Operating income | -$0.020827 | -$0.050208 | ||
Income from continuing operations | ||||
Net other income | -$0.150348 | |||
EBIT | -$0.020827 | -$0.050208 | ||
Interest expense | ||||
Income before tax | -$0.020827 | -$0.200556 | ||
Income tax expense | ||||
Minority interest | ||||
Net income from continuing ops | -$0.020827 | -$0.200556 | ||
Non-recurring events | ||||
Discontinued operations | ||||
Extraordinary items | ||||
Effect of accounting change | ||||
Other items | ||||
Net income | ||||
Net income | -$0.020827 | -$0.200556 | ||
Income (for common shares) | -$0.020827 | -$0.200556 |
Cash flows
(in millions USD) | 30 May 2009 | 27 Feb 2009 | |||
---|---|---|---|---|---|
Net income | -$0.005525 | -$0.00506 | |||
Operating activities | |||||
Depreciation | |||||
Net income adjustments | $0.00506 | $0.00506 | |||
Change in accounts receivable | |||||
Changes in liabilities | $0.000177 | ||||
Changes in inventory | |||||
Changes in other operating activities | |||||
Total cash flows from operations | -$0.000288 | -$0.000288 | |||
Investing activities | |||||
Capital expenditures | |||||
Investments | |||||
Other cash flows from investing | |||||
Total cash flows from investing | |||||
Financing activities | |||||
Dividends paid | |||||
Sale and purchase of stock | |||||
Net borrowings | $0.000288 | $0.000288 | |||
Other cash flows from financing | |||||
Total cash flows from financing | $0.000288 | $0.000288 | |||
Effect of exchange rate | |||||
Change in cash and equivalents |
(in millions USD) | 2009 | 2008 | ||
---|---|---|---|---|
Net income | -$0.020827 | -$0.200556 | ||
Operating activities | ||||
Depreciation | ||||
Net income adjustments | $0.02024 | $0.199098 | ||
Change in accounts receivable | $0.000396 | |||
Changes in liabilities | $0.0003 | $0.001068 | ||
Changes in inventory | ||||
Changes in other operating activities | ||||
Total cash flows from operations | -$0.000287 | $0.000006 | ||
Investing activities | ||||
Capital expenditures | ||||
Investments | ||||
Other cash flows from investing | ||||
Total cash flows from investing | ||||
Financing activities | ||||
Dividends paid | ||||
Sale and purchase of stock | ||||
Net borrowings | $0.000288 | $0.000288 | ||
Other cash flows from financing | ||||
Total cash flows from financing | $0.000288 | $0.000288 | ||
Effect of exchange rate | ||||
Change in cash and equivalents | $0.000001 | $0.000006 |
FCTI
Profit margin
Debt to assets
Cash flow
Balance sheet
(in millions USD) | 30 Oct 2021 | 30 Jul 2021 | |||
---|---|---|---|---|---|
Current assets | |||||
Cash | $0.000195 | $0.000279 | |||
Short term investments | |||||
Net receivables | |||||
Inventory | |||||
Other current assets | |||||
Total current assets | $0.000612 | $0.001321 | |||
Long term investments | |||||
Property, plant & equipment | |||||
Goodwill | |||||
Intangible assets | |||||
Other assets | |||||
Deferred long term asset charges | |||||
Total assets | $0.000612 | $0.001321 | |||
Current liabilities | |||||
Accounts payable | $0.103332 | $0.087959 | |||
Short long term debt | $0.479808 | ||||
Other current liabilities | $1.344982 | $0.840037 | |||
Total current liabilities | $2.192566 | $1.479316 | |||
Long term debt | $0.112259 | ||||
Other liabilities | |||||
Deferred long term liabilities | |||||
Minority interest | |||||
Total liabilities | $2.192566 | $1.591575 | |||
Stockholders' equity | |||||
Stock option warrants | |||||
Common stock | $0.055217 | $0.055217 | |||
Retained earnings | -$3.597437 | -$2.778867 | |||
Treasury stock | -$0.225 | -$0.45 | |||
Capital surplus | $1.575266 | $1.583396 | |||
Other stockholder equity | -$0.225 | -$0.45 | |||
Total stockholder equity | -$2.191954 | -$1.590254 | |||
Net tangible assets | -$2.191954 | -$1.590254 |
(in millions USD) | 2021 | 2020 | ||
---|---|---|---|---|
Current assets | ||||
Cash | $0.009945 | $0.000046 | ||
Short term investments | ||||
Net receivables | ||||
Inventory | ||||
Other current assets | ||||
Total current assets | $0.012237 | $0.000046 | ||
Long term investments | ||||
Property, plant & equipment | $0.00055 | |||
Goodwill | ||||
Intangible assets | ||||
Other assets | ||||
Deferred long term asset charges | ||||
Total assets | $0.012237 | $0.000596 | ||
Current liabilities | ||||
Accounts payable | $0.063665 | |||
Short long term debt | ||||
Other current liabilities | $0.469589 | |||
Total current liabilities | $0.664482 | $0.012763 | ||
Long term debt | ||||
Other liabilities | ||||
Deferred long term liabilities | ||||
Minority interest | ||||
Total liabilities | $0.664482 | $0.012763 | ||
Stockholders' equity | ||||
Stock option warrants | ||||
Common stock | $0.054217 | $0.069567 | ||
Retained earnings | -$1.302708 | -$0.042017 | ||
Treasury stock | $0.01998 | -$0.039717 | ||
Capital surplus | $0.576266 | |||
Other stockholder equity | $0.01998 | -$0.039717 | ||
Total stockholder equity | -$0.652245 | -$0.012167 | ||
Net tangible assets | -$0.652245 | -$0.012167 |
Income statement
(in millions USD) | 30 Oct 2021 | 30 Jul 2021 | |||
---|---|---|---|---|---|
Revenue | |||||
Total revenue | |||||
Cost of revenue | |||||
Gross profit | |||||
Operating activities | |||||
Research & development | |||||
Selling, general & administrative | $0.274819 | $0.267466 | |||
Non-recurring | |||||
Other operating expenses | |||||
Total operating expenses | $0.274819 | $0.267466 | |||
Operating income | -$0.274819 | -$0.267466 | |||
Income from continuing operations | |||||
Net other income | -$0.54901 | -$0.749399 | |||
EBIT | -$0.274819 | -$0.267466 | |||
Interest expense | -$0.044065 | -$0.207696 | |||
Income before tax | -$0.823829 | -$1.016865 | |||
Income tax expense | |||||
Minority interest | |||||
Net income from continuing ops | -$0.823829 | -$1.016865 | |||
Non-recurring events | |||||
Discontinued operations | |||||
Extraordinary items | |||||
Effect of accounting change | |||||
Other items | |||||
Net income | |||||
Net income | -$0.823829 | -$1.016865 | |||
Income (for common shares) | -$0.823829 | -$1.016865 |
(in millions USD) | 2021 | 2020 | ||
---|---|---|---|---|
Revenue | ||||
Total revenue | $0.0045 | |||
Cost of revenue | $0.0027 | |||
Gross profit | $0.0018 | |||
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | $0.447374 | $0.025585 | ||
Non-recurring | ||||
Other operating expenses | ||||
Total operating expenses | $0.447374 | $0.028285 | ||
Operating income | -$0.447374 | -$0.023785 | ||
Income from continuing operations | ||||
Net other income | -$0.813317 | |||
EBIT | -$0.447374 | -$0.023785 | ||
Interest expense | -$0.131228 | -$0.131228 | ||
Income before tax | -$1.260691 | -$0.023785 | ||
Income tax expense | ||||
Minority interest | ||||
Net income from continuing ops | -$1.260691 | -$0.023785 | ||
Non-recurring events | ||||
Discontinued operations | ||||
Extraordinary items | ||||
Effect of accounting change | ||||
Other items | ||||
Net income | ||||
Net income | -$1.260691 | -$0.023785 | ||
Income (for common shares) | -$1.260691 | -$0.023785 |
Cash flows
(in millions USD) | 30 Oct 2021 | 30 Jul 2021 | |||
---|---|---|---|---|---|
Net income | -$0.823829 | -$1.016865 | |||
Operating activities | |||||
Depreciation | |||||
Net income adjustments | $0.729945 | $0.890703 | |||
Change in accounts receivable | |||||
Changes in liabilities | $0.010373 | $0.005057 | |||
Changes in inventory | |||||
Changes in other operating activities | $0.069478 | $0.039725 | |||
Total cash flows from operations | -$0.000084 | -$0.031784 | |||
Investing activities | |||||
Capital expenditures | |||||
Investments | |||||
Other cash flows from investing | |||||
Total cash flows from investing | |||||
Financing activities | |||||
Dividends paid | |||||
Sale and purchase of stock | |||||
Net borrowings | $0.0295 | ||||
Other cash flows from financing | |||||
Total cash flows from financing | $0.0295 | ||||
Effect of exchange rate | |||||
Change in cash and equivalents | -$0.000084 | -$0.002284 |
(in millions USD) | 2021 | 2020 | ||
---|---|---|---|---|
Net income | -$1.260691 | -$0.023785 | ||
Operating activities | ||||
Depreciation | $0.0003 | $0.0004 | ||
Net income adjustments | $0.632339 | $0.632339 | ||
Change in accounts receivable | ||||
Changes in liabilities | $0.063665 | -$0.00275 | ||
Changes in inventory | ||||
Changes in other operating activities | $0.003908 | $0.003908 | ||
Total cash flows from operations | -$0.435451 | -$0.026135 | ||
Investing activities | ||||
Capital expenditures | ||||
Investments | ||||
Other cash flows from investing | ||||
Total cash flows from investing | ||||
Financing activities | ||||
Dividends paid | ||||
Sale and purchase of stock | ||||
Net borrowings | $0.37537 | $0.0029 | ||
Other cash flows from financing | ||||
Total cash flows from financing | $0.44535 | $0.0029 | ||
Effect of exchange rate | ||||
Change in cash and equivalents | $0.009899 | -$0.023235 |
Profit margin
Debt to assets
Cash flow
Balance sheet
(in millions USD) | 29 Jun 2017 | 30 Mar 2017 | |||
---|---|---|---|---|---|
Current assets | |||||
Cash | $0.00003 | $0.00002 | |||
Short term investments | |||||
Net receivables | |||||
Inventory | |||||
Other current assets | |||||
Total current assets | $0.00003 | $0.00002 | |||
Long term investments | |||||
Property, plant & equipment | |||||
Goodwill | |||||
Intangible assets | |||||
Other assets | |||||
Deferred long term asset charges | |||||
Total assets | $0.00003 | $0.00002 | |||
Current liabilities | |||||
Accounts payable | $0.015981 | $0.02239 | |||
Short long term debt | |||||
Other current liabilities | |||||
Total current liabilities | $0.165336 | $0.140087 | |||
Long term debt | |||||
Other liabilities | |||||
Deferred long term liabilities | |||||
Minority interest | |||||
Total liabilities | $0.165336 | $0.140087 | |||
Stockholders' equity | |||||
Stock option warrants | |||||
Common stock | $0.019912 | $0.018628 | |||
Retained earnings | -$5.157698 | -$1.65678 | |||
Treasury stock | |||||
Capital surplus | $4.97248 | $1.498085 | |||
Other stockholder equity | |||||
Total stockholder equity | -$0.165306 | -$0.140067 | |||
Net tangible assets | -$0.165306 | -$0.140067 |
(in millions USD) | 2016 | 2015 | ||
---|---|---|---|---|
Current assets | ||||
Cash | $0.00008 | $0.015445 | ||
Short term investments | ||||
Net receivables | ||||
Inventory | ||||
Other current assets | ||||
Total current assets | $0.00008 | $0.015445 | ||
Long term investments | ||||
Property, plant & equipment | ||||
Goodwill | ||||
Intangible assets | ||||
Other assets | ||||
Deferred long term asset charges | ||||
Total assets | $0.00008 | $0.015445 | ||
Current liabilities | ||||
Accounts payable | $0.006036 | $0.001529 | ||
Short long term debt | ||||
Other current liabilities | ||||
Total current liabilities | $0.103215 | $0.050603 | ||
Long term debt | ||||
Other liabilities | ||||
Deferred long term liabilities | ||||
Minority interest | ||||
Total liabilities | $0.103215 | $0.050603 | ||
Stockholders' equity | ||||
Stock option warrants | ||||
Common stock | $0.0725 | $0.0725 | ||
Retained earnings | -$0.137002 | -$0.069025 | ||
Treasury stock | -$0.038633 | -$0.038633 | ||
Capital surplus | ||||
Other stockholder equity | -$0.038633 | -$0.038633 | ||
Total stockholder equity | -$0.103135 | -$0.035158 | ||
Net tangible assets | -$0.103135 | -$0.035158 |
Income statement
(in millions USD) | 29 Jun 2017 | 30 Mar 2017 | |||
---|---|---|---|---|---|
Revenue | |||||
Total revenue | |||||
Cost of revenue | |||||
Gross profit | |||||
Operating activities | |||||
Research & development | |||||
Selling, general & administrative | $0.02524 | $0.036932 | |||
Non-recurring | |||||
Other operating expenses | |||||
Total operating expenses | $3.500919 | $1.519778 | |||
Operating income | -$3.500919 | -$1.519778 | |||
Income from continuing operations | |||||
Net other income | |||||
EBIT | -$3.500919 | -$1.519778 | |||
Interest expense | |||||
Income before tax | -$3.500919 | -$1.519778 | |||
Income tax expense | |||||
Minority interest | |||||
Net income from continuing ops | -$3.500919 | -$1.519778 | |||
Non-recurring events | |||||
Discontinued operations | |||||
Extraordinary items | |||||
Effect of accounting change | |||||
Other items | |||||
Net income | |||||
Net income | -$3.500919 | -$1.519778 | |||
Income (for common shares) | -$3.500919 | -$1.519778 |
(in millions USD) | 2016 | 2015 | ||
---|---|---|---|---|
Revenue | ||||
Total revenue | ||||
Cost of revenue | ||||
Gross profit | ||||
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | $0.067977 | $0.046402 | ||
Non-recurring | ||||
Other operating expenses | ||||
Total operating expenses | $0.067977 | $0.046402 | ||
Operating income | -$0.067977 | -$0.046402 | ||
Income from continuing operations | ||||
Net other income | ||||
EBIT | -$0.067977 | -$0.046402 | ||
Interest expense | ||||
Income before tax | -$0.067977 | -$0.046402 | ||
Income tax expense | ||||
Minority interest | ||||
Net income from continuing ops | -$0.067977 | -$0.046402 | ||
Non-recurring events | ||||
Discontinued operations | ||||
Extraordinary items | ||||
Effect of accounting change | ||||
Other items | ||||
Net income | ||||
Net income | -$0.067977 | -$0.046402 | ||
Income (for common shares) | -$0.067977 | -$0.046402 |
Cash flows
(in millions USD) | 29 Jun 2017 | 30 Mar 2017 | |||
---|---|---|---|---|---|
Net income | -$3.500919 | -$1.519778 | |||
Operating activities | |||||
Depreciation | |||||
Net income adjustments | $3.475678 | $1.482846 | |||
Change in accounts receivable | |||||
Changes in liabilities | -$0.006408 | $0.016354 | |||
Changes in inventory | |||||
Changes in other operating activities | |||||
Total cash flows from operations | -$0.031648 | -$0.020578 | |||
Investing activities | |||||
Capital expenditures | |||||
Investments | |||||
Other cash flows from investing | |||||
Total cash flows from investing | |||||
Financing activities | |||||
Dividends paid | |||||
Sale and purchase of stock | |||||
Net borrowings | $0.031658 | $0.020518 | |||
Other cash flows from financing | |||||
Total cash flows from financing | $0.031658 | $0.020518 | |||
Effect of exchange rate | |||||
Change in cash and equivalents | $0.00001 | -$0.00006 |
(in millions USD) | 2016 | 2015 | ||
---|---|---|---|---|
Net income | -$0.067977 | -$0.046402 | ||
Operating activities | ||||
Depreciation | ||||
Net income adjustments | ||||
Change in accounts receivable | ||||
Changes in liabilities | $0.004507 | $0.001529 | ||
Changes in inventory | ||||
Changes in other operating activities | ||||
Total cash flows from operations | -$0.06347 | -$0.044873 | ||
Investing activities | ||||
Capital expenditures | ||||
Investments | ||||
Other cash flows from investing | ||||
Total cash flows from investing | ||||
Financing activities | ||||
Dividends paid | ||||
Sale and purchase of stock | ||||
Net borrowings | $0.048105 | $0.051225 | ||
Other cash flows from financing | ||||
Total cash flows from financing | $0.048105 | $0.051225 | ||
Effect of exchange rate | ||||
Change in cash and equivalents | -$0.015365 | $0.006352 |
LVXID
Debt to assets
Cash flow
Balance sheet
(in millions USD) | 31 Mar 2023 | 31 Dec 2022 | |||
---|---|---|---|---|---|
Current assets | |||||
Cash | $0.073 | $0.211 | |||
Short term investments | |||||
Net receivables | $0.193 | $0.193 | |||
Inventory | |||||
Other current assets | |||||
Total current assets | $0.266 | $0.405 | |||
Long term investments | |||||
Property, plant & equipment | $0.042 | $0.048 | |||
Goodwill | |||||
Intangible assets | $0.003 | ||||
Other assets | |||||
Deferred long term asset charges | |||||
Total assets | $0.312 | $0.453 | |||
Current liabilities | |||||
Accounts payable | $0.021 | $0.005 | |||
Short long term debt | $0.842 | $0.878 | |||
Other current liabilities | $2.82 | $1.76 | |||
Total current liabilities | $4.05 | $2.99 | |||
Long term debt | |||||
Other liabilities | -$0.842 | -$0.878 | |||
Deferred long term liabilities | |||||
Minority interest | |||||
Total liabilities | $4.05 | $2.99 | |||
Stockholders' equity | |||||
Stock option warrants | |||||
Common stock | $0.008 | $0.005 | |||
Retained earnings | -$38.06 | -$36.7 | |||
Treasury stock | |||||
Capital surplus | |||||
Other stockholder equity | |||||
Total stockholder equity | -$3.74 | -$2.54 | |||
Net tangible assets |
(in millions USD) | 2022 | 2021 | ||
---|---|---|---|---|
Current assets | ||||
Cash | $0.211 | $1.937 | ||
Short term investments | ||||
Net receivables | $0.193 | $0.193 | ||
Inventory | ||||
Other current assets | ||||
Total current assets | $0.405 | $1.16 | ||
Long term investments | ||||
Property, plant & equipment | $0.048 | |||
Goodwill | ||||
Intangible assets | ||||
Other assets | ||||
Deferred long term asset charges | ||||
Total assets | $0.453 | $1.16 | ||
Current liabilities | ||||
Accounts payable | $0.005 | $0.023 | ||
Short long term debt | $0.878 | $1.08 | ||
Other current liabilities | $1.76 | $5.18 | ||
Total current liabilities | $2.99 | $6.54 | ||
Long term debt | ||||
Other liabilities | -$0.878 | -$1.08 | ||
Deferred long term liabilities | ||||
Minority interest | ||||
Total liabilities | $2.99 | $6.54 | ||
Stockholders' equity | ||||
Stock option warrants | ||||
Common stock | $0.005 | $0.002 | ||
Retained earnings | -$36.7 | -$38.88 | ||
Treasury stock | ||||
Capital surplus | ||||
Other stockholder equity | ||||
Total stockholder equity | -$2.54 | -$5.38 | ||
Net tangible assets |
Income statement
(in millions USD) | |
---|---|
Revenue | |
Total revenue | |
Cost of revenue | |
Gross profit | |
Operating activities | |
Research & development | |
Selling, general & administrative | |
Non-recurring | |
Other operating expenses | |
Total operating expenses | |
Operating income | |
Income from continuing operations | |
Net other income | |
EBIT | |
Interest expense | |
Income before tax | |
Income tax expense | |
Minority interest | |
Net income from continuing ops | |
Non-recurring events | |
Discontinued operations | |
Extraordinary items | |
Effect of accounting change | |
Other items | |
Net income | |
Net income | |
Income (for common shares) |
(in millions USD) | 2017 | |
---|---|---|
Revenue | ||
Total revenue | $0.05 | |
Cost of revenue | $0.06 | |
Gross profit | -$0.01 | |
Operating activities | ||
Research & development | ||
Selling, general & administrative | $4.85 | |
Non-recurring | ||
Other operating expenses | ||
Total operating expenses | $4.92 | |
Operating income | -$4.86 | |
Income from continuing operations | ||
Net other income | ||
EBIT | ||
Interest expense | ||
Income before tax | -$7.39 | |
Income tax expense | ||
Minority interest | ||
Net income from continuing ops | ||
Non-recurring events | ||
Discontinued operations | ||
Extraordinary items | ||
Effect of accounting change | ||
Other items | ||
Net income | ||
Net income | -$7.39 | |
Income (for common shares) | -$7.39 |
Cash flows
(in millions USD) | 31 Mar 2023 | 31 Dec 2022 | |||
---|---|---|---|---|---|
Net income | -$1.36 | -$0.666 | |||
Operating activities | |||||
Depreciation | $0.003 | $0.003 | |||
Net income adjustments | |||||
Change in accounts receivable | |||||
Changes in liabilities | |||||
Changes in inventory | |||||
Changes in other operating activities | |||||
Total cash flows from operations | -$0.138 | -$0.165 | |||
Investing activities | |||||
Capital expenditures | |||||
Investments | |||||
Other cash flows from investing | |||||
Total cash flows from investing | |||||
Financing activities | |||||
Dividends paid | |||||
Sale and purchase of stock | |||||
Net borrowings | -$0.1 | ||||
Other cash flows from financing | |||||
Total cash flows from financing | -$0.1 | ||||
Effect of exchange rate | |||||
Change in cash and equivalents | -$0.138 | -$0.265 |
(in millions USD) | 2022 | 2021 | ||
---|---|---|---|---|
Net income | $2.18 | $90.76 | ||
Operating activities | ||||
Depreciation | $0.006 | |||
Net income adjustments | ||||
Change in accounts receivable | ||||
Changes in liabilities | ||||
Changes in inventory | ||||
Changes in other operating activities | ||||
Total cash flows from operations | -$0.66 | -$0.901 | ||
Investing activities | ||||
Capital expenditures | -$0.054 | |||
Investments | ||||
Other cash flows from investing | -$0.008 | |||
Total cash flows from investing | -$0.054 | -$0.008 | ||
Financing activities | ||||
Dividends paid | ||||
Sale and purchase of stock | $1.25 | |||
Net borrowings | -$0.042 | $0.566 | ||
Other cash flows from financing | ||||
Total cash flows from financing | -$0.042 | $1.81 | ||
Effect of exchange rate | ||||
Change in cash and equivalents | -$0.756 | $0.905 |
BLGID
Profit margin
Debt to assets
Cash flow
Balance sheet
(in millions USD) | 31 Jan 2021 | 31 Oct 2020 | |||
---|---|---|---|---|---|
Current assets | |||||
Cash | $0.01 | ||||
Short term investments | |||||
Net receivables | |||||
Inventory | |||||
Other current assets | |||||
Total current assets | $0.01 | $0.01 | |||
Long term investments | |||||
Property, plant & equipment | |||||
Goodwill | |||||
Intangible assets | |||||
Other assets | |||||
Deferred long term asset charges | |||||
Total assets | $0.01 | $0.01 | |||
Current liabilities | |||||
Accounts payable | $0.35 | $0.35 | |||
Short long term debt | $2.6 | $2.37 | |||
Other current liabilities | |||||
Total current liabilities | $3.48 | $3.3 | |||
Long term debt | |||||
Other liabilities | |||||
Deferred long term liabilities | |||||
Minority interest | |||||
Total liabilities | $3.48 | $3.3 | |||
Stockholders' equity | |||||
Stock option warrants | |||||
Common stock | $0.5 | ||||
Retained earnings | -$14.53 | -$13.68 | |||
Treasury stock | |||||
Capital surplus | |||||
Other stockholder equity | |||||
Total stockholder equity | -$3.48 | -$3.29 | |||
Net tangible assets |
(in millions USD) | 2020 | 2019 | ||
---|---|---|---|---|
Current assets | ||||
Cash | ||||
Short term investments | ||||
Net receivables | ||||
Inventory | ||||
Other current assets | ||||
Total current assets | $0.01 | |||
Long term investments | ||||
Property, plant & equipment | ||||
Goodwill | ||||
Intangible assets | ||||
Other assets | ||||
Deferred long term asset charges | ||||
Total assets | $0.01 | |||
Current liabilities | ||||
Accounts payable | $0.35 | $0.35 | ||
Short long term debt | $2.18 | $1.43 | ||
Other current liabilities | ||||
Total current liabilities | $2.91 | $2.36 | ||
Long term debt | ||||
Other liabilities | ||||
Deferred long term liabilities | ||||
Minority interest | ||||
Total liabilities | $2.91 | $2.36 | ||
Stockholders' equity | ||||
Stock option warrants | ||||
Common stock | $0.44 | $0.44 | ||
Retained earnings | -$11.08 | -$10.49 | ||
Treasury stock | ||||
Capital surplus | ||||
Other stockholder equity | ||||
Total stockholder equity | -$2.91 | -$2.35 | ||
Net tangible assets |
Income statement
(in millions USD) | 30 Jul 2020 | 29 Apr 2020 | |||
---|---|---|---|---|---|
Revenue | |||||
Total revenue | |||||
Cost of revenue | $1.24555 | ||||
Gross profit | -$1.24555 | ||||
Operating activities | |||||
Research & development | |||||
Selling, general & administrative | $0.16174 | $0.086489 | |||
Non-recurring | |||||
Other operating expenses | |||||
Total operating expenses | $1.40729 | $0.086489 | |||
Operating income | -$1.40729 | -$0.086489 | |||
Income from continuing operations | |||||
Net other income | -$0.143816 | -$0.133551 | |||
EBIT | -$1.40729 | -$0.086489 | |||
Interest expense | -$0.142811 | -$0.136646 | |||
Income before tax | -$1.551106 | -$0.22004 | |||
Income tax expense | |||||
Minority interest | |||||
Net income from continuing ops | -$1.551106 | -$0.22004 | |||
Non-recurring events | |||||
Discontinued operations | |||||
Extraordinary items | |||||
Effect of accounting change | |||||
Other items | |||||
Net income | |||||
Net income | -$1.551106 | -$0.22004 | |||
Income (for common shares) | -$1.551106 | -$0.22004 |
(in millions USD) | 2020 | 2019 | ||
---|---|---|---|---|
Revenue | ||||
Total revenue | ||||
Cost of revenue | ||||
Gross profit | ||||
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | $0.099506 | $0.295507 | ||
Non-recurring | ||||
Other operating expenses | ||||
Total operating expenses | $0.099506 | $2.510061 | ||
Operating income | -$0.099506 | -$2.510061 | ||
Income from continuing operations | ||||
Net other income | -$0.497059 | -$1.784791 | ||
EBIT | -$0.099506 | -$2.510061 | ||
Interest expense | -$0.500154 | -$1.511958 | ||
Income before tax | -$0.596565 | -$4.294852 | ||
Income tax expense | ||||
Minority interest | ||||
Net income from continuing ops | -$0.596565 | -$4.294852 | ||
Non-recurring events | ||||
Discontinued operations | ||||
Extraordinary items | ||||
Effect of accounting change | ||||
Other items | ||||
Net income | ||||
Net income | -$0.596565 | -$4.294852 | ||
Income (for common shares) | -$0.596565 | -$4.294852 |
Cash flows
(in millions USD) | 31 Jan 2021 | 31 Oct 2020 | |||
---|---|---|---|---|---|
Net income | -$0.84 | -$1.05 | |||
Operating activities | |||||
Depreciation | |||||
Net income adjustments | |||||
Change in accounts receivable | |||||
Changes in liabilities | |||||
Changes in inventory | |||||
Changes in other operating activities | |||||
Total cash flows from operations | -$0.26 | -$0.07 | |||
Investing activities | |||||
Capital expenditures | |||||
Investments | |||||
Other cash flows from investing | |||||
Total cash flows from investing | |||||
Financing activities | |||||
Dividends paid | |||||
Sale and purchase of stock | $0.1 | ||||
Net borrowings | $0.16 | $0.07 | |||
Other cash flows from financing | |||||
Total cash flows from financing | $0.26 | $0.07 | |||
Effect of exchange rate | |||||
Change in cash and equivalents | $0.01 |
(in millions USD) | 2020 | 2019 | ||
---|---|---|---|---|
Net income | -$0.6 | -$4.29 | ||
Operating activities | ||||
Depreciation | ||||
Net income adjustments | ||||
Change in accounts receivable | ||||
Changes in liabilities | ||||
Changes in inventory | ||||
Changes in other operating activities | ||||
Total cash flows from operations | -$0.02 | -$0.15 | ||
Investing activities | ||||
Capital expenditures | ||||
Investments | ||||
Other cash flows from investing | ||||
Total cash flows from investing | ||||
Financing activities | ||||
Dividends paid | ||||
Sale and purchase of stock | ||||
Net borrowings | $0.02 | $0.17 | ||
Other cash flows from financing | -$0.01 | |||
Total cash flows from financing | $0.02 | $0.15 | ||
Effect of exchange rate | ||||
Change in cash and equivalents |